Forte Biosciences, Inc. Common Stock (FBRX)
Since May 16, 2022, Forte Biosciences, Inc. Common Stock (FBRX) has reported earnings 13 times. On average the shares move ±4.56% post-earnings, with a positive reaction 61.5% of the time. Its largest post-earnings gain was +7.46% (Aug 14, 2025) and its largest decline was -25.03% (Aug 14, 2024). The next earnings report is predicted for 2026-08-14 (high confidence).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
13
Avg Abs. Movement
±4.56%
Positive %
61.5%
Negative %
38.5%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | ☽ POST | $24.32 | $24.83 | $24.06 | 5,081 | -4.18% | open_in_new |
| Apr 01, 2026 | ☀ PRE | $27.75 | $27.80 | $24.89 | 15,032 | -2.18% | open_in_new |
| Nov 14, 2025 | ☀ PRE | $14.01 | $14.63 | $14.13 | 1,897 | +2.61% | open_in_new |
| Aug 14, 2025 | ☽ POST | $10.87 | $10.87 | $10.87 | 0 | +7.46% | open_in_new |
| May 15, 2025 | ☽ POST | $7.95 | $7.95 | $7.95 | 194 | -1.26% | open_in_new |
| Nov 14, 2024 | ☽ POST | $5.58 | $5.58 | $5.58 | 120 | +4.66% | open_in_new |
| Aug 14, 2024 | ☽ POST | $0.40 | $0.40 | $0.39 | 316 | -25.03% | open_in_new |
| May 13, 2024 | ☽ POST | $0.73 | $0.73 | $0.73 | 0 | +0% | open_in_new |
| Mar 18, 2024 | ☽ POST | $0.62 | $0.64 | $0.64 | 408 | +0% | open_in_new |
| Mar 31, 2023 | ☽ POST | $0.98 | $0.98 | $0.98 | 0 | +0% | open_in_new |
| Nov 14, 2022 | ☽ POST | $1.00 | $1.00 | $1.00 | 183 | +0% | open_in_new |
| Aug 15, 2022 | ☽ POST | $1.30 | $1.30 | $1.29 | 7,676 | +1.54% | open_in_new |
| May 16, 2022 | ☀ PRE | $1.12 | $1.12 | $1.07 | 2,175 | -10.42% | open_in_new |
Earnings Count
13
Total earnings in dataset
Avg Abs. Movement
±4.56%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| S-3/A | 20260608 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260608 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
| 4 | 20260602 | open_in_new SEC.gov |
| 8-K | 20260602 | open_in_new SEC.gov |
| S-3 | 20260602 | open_in_new SEC.gov |
Frequently asked about FBRX earnings
When does Forte Biosciences, Inc. Common Stock report earnings next? expand_more
Forte Biosciences, Inc. Common Stock (FBRX)'s next earnings date is predicted (high confidence) for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does FBRX stock move after earnings? expand_more
Over 13 reports, FBRX has moved an average of ±4.56% the session after earnings, closing higher 61.5% of the time.
What was FBRX's biggest post-earnings move? expand_more
FBRX's largest post-earnings gain on record was +7.46% on Aug 14, 2025, and its largest decline was -25.03% on Aug 14, 2024.
Where can I find Forte Biosciences, Inc. Common Stock's SEC filings? expand_more
All of Forte Biosciences, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right